Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | Proteasome subunit beta type 2 | 0.0308 | 0.3546 | 0.3546 |
Trypanosoma brucei | proteasome subunit beta type-2, putative | 0.0308 | 0.3546 | 0.3546 |
Leishmania major | proteasome beta 5 subunit, putative | 0.0685 | 1 | 1 |
Trichomonas vaginalis | Family T1, proteasome beta subunit, threonine peptidase | 0.0308 | 0.3546 | 0.3546 |
Trypanosoma cruzi | 20S proteasome subunit | 0.0308 | 0.3546 | 0.3546 |
Trypanosoma cruzi | proteasome subunit beta type-5, putative | 0.0685 | 1 | 1 |
Trypanosoma cruzi | proteasome subunit beta type-2, putative | 0.0308 | 0.3546 | 0.3546 |
Mycobacterium tuberculosis | Proteasome beta subunit PrcB; assembles with alpha subunit PrcA. | 0.0685 | 1 | 1 |
Giardia lamblia | Proteasome subunit beta type 5 precursor | 0.0685 | 1 | 1 |
Echinococcus multilocularis | proteasome (prosome, macropain) | 0.0685 | 1 | 1 |
Toxoplasma gondii | proteasome subunit beta type 2, putative | 0.0308 | 0.3546 | 0.3546 |
Brugia malayi | proteasome subunit beta type 1 | 0.0152 | 0.0868 | 0.0868 |
Entamoeba histolytica | proteasome subunit beta type 5 precursor, putative | 0.0685 | 1 | 1 |
Brugia malayi | proteasome subunit beta type 2 | 0.0308 | 0.3546 | 0.3546 |
Plasmodium falciparum | proteasome subunit beta type-2, putative | 0.0308 | 0.3546 | 0.3546 |
Mycobacterium leprae | proteasome (beta subunit) PrcB | 0.0685 | 1 | 1 |
Trypanosoma cruzi | proteasome beta 6 subunit, putative | 0.0152 | 0.0868 | 0.0868 |
Trypanosoma brucei | proteasome beta 6 subunit | 0.0152 | 0.0868 | 0.0868 |
Entamoeba histolytica | proteasome subunit beta type 1, putative | 0.0152 | 0.0868 | 0.0868 |
Plasmodium vivax | proteasome subunit beta type-1, putative | 0.0152 | 0.0868 | 0.0868 |
Toxoplasma gondii | proteasome subunit beta type, putative | 0.0685 | 1 | 1 |
Trichomonas vaginalis | Family T1, proteasome beta subunit, threonine peptidase | 0.0152 | 0.0868 | 0.0868 |
Echinococcus multilocularis | proteasome (prosome, macropain) subunit, beta | 0.0152 | 0.0868 | 0.0868 |
Schistosoma mansoni | proteasome subunit beta 1 (T01 family) | 0.0152 | 0.0868 | 0.0868 |
Echinococcus granulosus | proteasome prosome macropain subunit beta | 0.0308 | 0.3546 | 0.3546 |
Trypanosoma cruzi | proteasome beta 6 subunit, putative | 0.0152 | 0.0868 | 0.0868 |
Giardia lamblia | Proteasome subunit beta type 1 | 0.0152 | 0.0868 | 0.0868 |
Leishmania major | proteasome beta 6 subunit, putative,20S proteasome beta 6 subunit, putative | 0.0152 | 0.0868 | 0.0868 |
Onchocerca volvulus | Notchless protein homolog | 0.0101 | 0 | 0.5 |
Echinococcus multilocularis | proteasome (prosome, macropain) subunit, beta | 0.0308 | 0.3546 | 0.3546 |
Plasmodium falciparum | proteasome subunit beta type-5 | 0.0685 | 1 | 1 |
Trypanosoma cruzi | proteasome subunit beta type-5, putative | 0.0685 | 1 | 1 |
Loa Loa (eye worm) | proteasome subunit beta type 2 | 0.0308 | 0.3546 | 0.3546 |
Entamoeba histolytica | probable proteasome subunit beta type 2, putative | 0.0308 | 0.3546 | 0.3546 |
Plasmodium vivax | proteasome subunit beta type-2, putative | 0.0308 | 0.3546 | 0.3546 |
Echinococcus granulosus | proteasome prosome macropain | 0.0685 | 1 | 1 |
Mycobacterium ulcerans | proteasome PrcB | 0.0685 | 1 | 1 |
Toxoplasma gondii | proteasome subunit beta type 1, putative | 0.0152 | 0.0868 | 0.0868 |
Wolbachia endosymbiont of Brugia malayi | ATP-dependent protease peptidase subunit | 0.0101 | 0 | 0.5 |
Trypanosoma brucei | proteasome subunit beta type-5, putative | 0.0685 | 1 | 1 |
Leishmania major | proteasome beta 2 subunit, putative | 0.0308 | 0.3546 | 0.3546 |
Plasmodium vivax | proteasome subunit beta type-5, putative | 0.0685 | 1 | 1 |
Plasmodium falciparum | proteasome subunit beta type-1, putative | 0.0152 | 0.0868 | 0.0868 |
Trichomonas vaginalis | Family T1, proteasome beta subunit, threonine peptidase | 0.0308 | 0.3546 | 0.3546 |
Schistosoma mansoni | proteasome subunit beta 2 (T01 family) | 0.0308 | 0.3546 | 0.3546 |
Schistosoma mansoni | proteasome subunit beta 2 (T01 family) | 0.0308 | 0.3546 | 0.3546 |
Schistosoma mansoni | proteasome catalytic subunit 3 (T01 family) | 0.0685 | 1 | 1 |
Echinococcus granulosus | proteasome prosome macropain subunit beta | 0.0152 | 0.0868 | 0.0868 |
Loa Loa (eye worm) | proteasome subunit beta type 1 | 0.0152 | 0.0868 | 0.0868 |
Trichomonas vaginalis | Family T1, proteasome beta subunit, threonine peptidase | 0.0685 | 1 | 1 |
Loa Loa (eye worm) | proteasome A-type and B-type family protein | 0.0685 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 3.1623 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human Muscle isoform 2 Pyruvate Kinase. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase. (Class of assay: confirmatory) [Related pubchem assays: 1379 ] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.